Skip to main content
    D

    Dolby Laboratories (DLB)

    Official site

    INDUSTRIALS • SPECIALTY BUSINESS SERVICES • NYSE

    $58.64
    -2.52 (-4.12%)

    Market Cap: $5.73B

    Last updated: Nov 17, 2026 at 4:43 PM ET

    Dolby Laboratories (DLB) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Dolby Laboratories (DLB) has a market cap of $5.73B and an enterprise value of $5.11B. Its trailing P/E of 15.2x is below its 10-year median of 22.2x. It holds $622.88M more cash than debt, 10.87% of its market cap.

    Total Valuation

    Enterprise value is 10.87% below the market cap, as cash exceeds debt.

    Market Cap$5.73B
    Enterprise Value$5.11B
    Latest price (Nov 17, 2026)$58.64

    Key Dates

    The next earnings report is set for Nov 17, 2026, after the close. The last ex-dividend date was Aug 11, 2026.

    Next Earnings DateNov 17, 2026, after the close
    Last Earnings DateJul 30, 2026
    Last Ex-Dividend DateAug 11, 2026
    Last Payment DateAug 19, 2026
    Fiscal Year EndSeptember

    Share Statistics

    The share count fell 1.03% in the quarter ended Jun 30, 2026 and shrank 0.76% a year over 2 years.

    Shares Outstanding94.57M
    Shares Change (YoY)-1.73%
    Shares Change (QoQ)-1.03%
    Share Count Growth (2Y CAGR)-0.76%

    Valuation Ratios

    Sales and book value multiples are 3.9x and 2.1x. Its year-end P/E ranged from 15.4x to 29.7x from 2016 to 2025.

    P/E Ratio15.2x
    Forward P/E12.7x
    P/S Ratio3.9x
    Forward P/S3.9x
    P/B Ratio2.1x
    P/TBV Ratio3.3x
    P/FCF Ratio15.4x
    P/OCF Ratio14.3x
    PEG Ratio1.8

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 11.6x EBITDA and 13.7x free cash flow.

    EV / Earnings19.7x
    EV / Sales3.6x
    EV / EBITDA11.6x
    EV / FCF13.7x

    Price Statistics

    The stock is down 9.01% over 52 weeks and trades 3.71% below its 50-day average.

    Beta (1Y)0.54
    52-Week Change-9.01%
    1-Month Change-3.96%
    3-Month Change-6.48%
    6-Month Change+10.52%
    5-Year Change-29.84%
    10-Year Change+30.26%
    Total Return (1Y)-6.77%
    Total Return (3Y CAGR)-8.94%
    Total Return (5Y CAGR)-6.89%
    Return vs SPY (1Y)-19.73%
    Max Drawdown (1Y)-29.74%
    Max Drawdown (3Y)-43.53%
    Sharpe Ratio (1Y)-0.29
    Correlation with SPY (1Y)0.25
    50-Day Average$60.90
    200-Day Average$59.03
    52-Week Range$47.98 to $69.11
    RSI (14 Days)32.8
    Average Volume (20 Days)900.23K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 3.18x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio3.18x
    Quick Ratio3.11x
    Debt / Equity0.00x
    Interest Coverage-19.24x

    Returns and Efficiency

    Return on equity is 9.97% over the last 12 months, against a 5-year average of 9.43%.

    Return on Equity (ROE)9.97%
    Return on Assets (ROA)8.19%
    ROE (5Y Average)9.43%
    ROA (5Y Average)7.65%
    ROIC (5Y Average)9.42%
    Asset Turnover0.44x
    Inventory Turnover6.30x
    Receivables Turnover4.85x
    Cash Conversion Cycle102 days

    Taxes

    Income tax took 23.08% of pretax income over the last 12 months.

    Income Tax (TTM)$77.86M
    Effective Tax Rate23.08%

    Scores

    DLB has an Altman Z-Score of 8.27, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score8.27
    Altman Z ZoneSafe
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $1.42B over the last 12 months is up 5.32% from the 12 months before.

    Revenue$1.42B
    Revenue Growth (YoY)+5.32%
    Gross Profit$1.23B
    Operating Income$303.99M
    Pretax Income$337.38M
    Net Income$259.52M
    EBITDA$425.98M
    Reported EPS (TTM)$3.85

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 82.02% of the $3.17B in total assets.

    Cash and Equivalents$622.88M
    Total Debt$0
    Net Cash$622.88M
    Net Cash Per Share$6.59
    Working Capital$911.39M
    Shareholder Equity$2.60B
    Book Value Per Share$27.53
    Tangible Book Value$1.69B
    Tangible Book Per Share$17.82
    Total Assets$3.17B
    Total Liabilities$556.01M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $39.63M of capital spending, operating cash flow left $359.91M of free cash flow.

    Operating Cash Flow$399.55M
    Capital Expenditures$39.63M
    Free Cash Flow$359.91M
    FCF Per Share$6.06
    Depreciation and Amortization$105.27M
    Dividends Paid$138.54M
    Share Repurchases$299.62M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 21.39%, against a 5-year average of 18.88%.

    Gross Margin86.87%
    Operating Margin21.39%
    Pretax Margin23.74%
    Net Margin18.27%
    EBITDA Margin29.98%
    FCF Margin25.33%
    Gross Margin (5Y Average)88.19%
    Operating Margin (5Y Average)18.88%
    Net Margin (5Y Average)17.64%

    Growth

    Revenue grew 3.01% a year over 3 years, and EPS fell 7.12% a year.

    Revenue Growth (3Y CAGR)+3.01%
    Revenue Growth (5Y CAGR)+2.09%
    EPS Growth (3Y CAGR)-7.12%
    EPS Growth (5Y CAGR)-4.92%
    FCF Growth (3Y CAGR)+2.24%
    FCF Growth (5Y CAGR)-1.76%
    Operating Income Growth (3Y CAGR)+12.11%
    Book Value Per Share Growth (2Y CAGR)+5.98%
    Tangible Book Per Share Growth (2Y CAGR)-1.96%

    Revenue and profit by year

    Dividends and Yields

    DLB pays out 34.08% of earnings as dividends.

    Dividend Per Share (Annual)$1.44
    Dividend Yield2.46%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+9.79%
    Dividend Growth (5Y CAGR)+8.94%
    Payout Ratio34.08%
    FCF Payout Ratio38.49%
    Earnings Yield6.58%
    FCF Yield6.49%
    Buyback Yield5.40%
    Shareholder Yield7.90%

    Full dividend history

    Peer Position

    Against 10 similar companies, DLB has the 7th highest P/E.

    P/E Ratio15.2x vs 20.6x median
    P/S Ratio3.9x vs 1.1x median
    Revenue Growth (Trailing 4 Quarters, YoY)+5.32% vs +14.35% median
    Dividend Yield2.46% vs 0.81% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 3.26% and EPS growth at 60.14% a year over the next fiscal year.

    Revenue Growth Forecast (1Y CAGR)+3.26%
    EPS Growth Forecast (1Y CAGR)+60.14%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About DLB

    What is DLB's market cap?

    Dolby Laboratories has a market cap of $5.73B. Its enterprise value, which adds debt and subtracts cash, is $5.11B.

    What is DLB's P/E ratio?

    Dolby Laboratories has a trailing P/E ratio of 15.2x and a forward P/E of 12.7x.

    How many shares of DLB are outstanding?

    Dolby Laboratories has 94.57M shares outstanding. The count is down 1.73% from a year earlier.

    Does DLB pay a dividend?

    Yes. Dolby Laboratories pays $1.44 a share a year, a dividend yield of 2.46%.

    How much debt does DLB have?

    Dolby Laboratories has $0 of total debt and $622.88M of cash and equivalents, a net cash position of $622.88M.